All News

Researchers observed that migraine was associated with an increased risk of developing a cochlear disorder, especially tinnitus.

New tools from the American College of Chest Physicians' CHEST Foundation, the Allergy & Asthma Network, and the American College of Allergy, Asthma & Immunology can help clinicians and patients to work together to choose the best treatment and increase adherence.

A recent systematic review and meta-analysis published in The Lancet Oncology found that men with advanced cancers respond better than women to treatment with anti-PD-1 or anti-CTLA-4 immune checkpoint inhibitors.

According to a report, existing HIV tools and strategies are insufficient, and despite historic breakthroughs in maximizing prevention and treatment strategies, the HIV pandemic will likely continue to be a global challenge for the foreseeable future.

A recent study published in Radiology found that evaluating the differences in iron accumulation in the deep gray matter of the brain using a magnetic resonance imaging (MRI) technique may help to identify patients with multiple sclerosis (MS) that are at greater risk for disease progression and disability.

A solution has been found to maintain a version of a free government website that has hosted clinical guidelines, but now users will have to pay for access.

For vulnerable populations, their health and healthcare issues may be exacerbated by social factors. Here are just 5 vulnerable populations who experience greater risk factors, worse access to care, and increased morbidity and mortality compared with the general population.

Nearly half of patients visiting urgent care centers who were diagnosed with an acute respiratory condition, for which antibiotics are neither recommended nor effective, walked away with an antibiotic prescription anyway.

Do e-cigarettes help current smokers quit, or do they just become an additional nicotine habit? A new study of more than 30,000 adults in Sweden indicates that traditional smokers use both methods.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A study of more than 97,000 elderly patients with hip fracture found they were not often prescribed osteoporosis medications in an effort to prevent future fractures, and in fact, the rates declined over 12 years—a finding that surprised researchers.

The FDA has expanded its approval of ribociclib (Kisqali) to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer under 2 new pilot programs to make the development and review of cancer drugs more efficient.

A recent review of the benefits and safety of dietary protein for bone health concluded that a protein-rich diet is beneficial for adult bone health.

Senate Democrats are urging Republicans to agree to a resolution that would allow the Senate to intervene in a lawsuit challenging the legality of the Affordable Care Act; the after effects of Hurricane Maria are helping to fuel an exodus of physicians from Puerto Rico; a new congressional report suggests Anthem has effectively reversed a policy denying emergency department claims after the fact.

Recent research has suggested that small airway disease is a pathological feature in mild and moderate chronic obstructive pulmonary disease (COPD) and that early intervention for disease modification may be required in these patients.

This week, the top managed care stories included patient advocates, providers, payers, and pharma commenting on the Trump administration's drug pricing plan; a survey that found physicians and payers believe progress toward value-based care is slowing; a study that questions the standards of evidence for breakthrough therapy approvals.

For the first time, HHS and the FDA said Thursday the idea of allowing the importation of prescription drugs from other countries will be considered, if the drug met certain conditions.

Sulfonylureas are an older class of type 2 diabetes therapy but remain the most commonly prescribed antidiabetic drug after metformin.

Rebekah Gee, MD, Louisiana’s secretary of the Department of Health, is working on innovative solutions to ensure patient access to costly drugs within existing financial resources.

Patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who have short telomeres, a biomarker of aging, are more likely to have a worse quality of life and have a higher risk of exacerbations and death, according to a recent study, but daily azithromycin may help.

A recent study published in the European Journal of Clinical Nutrition found that healthcare professionals are downplaying the importance of patients with multiple sclerosis (MS) following national dietary guidelines.

Recent data shows how common combination coprescribing of opioids with a triptan or a serotonergic antidepressant was just 2 years prior to an FDA warning about the risk of serotonin syndrome from such coprescribing.

FDA Commissioner Scott Gottlieb, MD, announced the release of the agency’s Biosimilar Action Plan; Philadelphia’s tax on soda and other sweetened beverages has been upheld by the Pennsylvania Supreme Court; a federal judge dismissed a lawsuit by 19 states against the Trump administration over the decision to end cost-sharing subsidies under the Affordable Care Act.

Findings were consistent with earlier studies that link long work hours and diabetes as well as long periods of sitting with diabetes and obesity.

After 5 years of research, the Hutchinson Institute for Cancer Outcomes Research has released a report that is the first in the nation to publicly report clinic-level quality measures linked to cost in oncology.

The Swiss drug maker is the second pharmaceutical company to announce a halt to price hikes, coming after Pfizer's decision last week to reverse planned increases.

Unplanned hospital readmissions, which affect more than 18% of Medicare beneficiaries each year, are generally understood to be tied to gaps in care coordination between hospitals and community healthcare providers, and new research suggests that readmission more than a week after discharge may be tied to patients’ inability to access appropriate outpatient care after discharge.

Janssen announced the approval of Symtuza (darunavir 800 mg, cobistat 150 mg, emtricitabine 200 mg, and tenofovir alafenamide 10 mg) for the treatment of HIV-1 in treatment-naïve and certain virologically suppressed patients.

Genentech announced yesterday that the FDA has granted Breakthrough Therapy Designation to atezolizumab (Tecentriq) in combination with bevacizumab (Avastin) as a first-line treatment for patients with the most common form of liver cancer, advanced or metastatic hepatocellular carcinoma (HCC).

A new study published in JAMA reviewed the premarket development and review times of drugs approved between 2012 and 2017 that were granted Breakthrough Therapy designation and found that the crucial studies that supported these approvals lacked key features, including randomization, double-blinding, and control groups.